U.S. Metals and Mining Stock News

Textron’s Bell unit recently secured orders from South Africa’s National Transmission Company for seven Bell 407GX helicopters and from the Pasadena Police Department for two Bell 505 helicopters, all designated for utility and public safety missions. These contracts highlight how Textron is extending the reach of its helicopter portfolio into both international infrastructure work and specialized municipal law‑enforcement operations. Next, we’ll examine how these new helicopter orders,...

Eversept Partners has made a significant institutional investment in Avantor (NYSE:AVTR), increasing its ownership stake in the company. The move comes as Avantor presses ahead with its Revival program, which is aimed at responding to prolonged organic revenue declines and restructuring efforts. These ownership changes and internal initiatives are drawing fresh attention to Avantor's potential direction and risk profile. Avantor supplies products and services to the life sciences and...

Wondering if HEICO at around US$292.21 is still offering value, or if the best days are already priced in? This article focuses squarely on what you are paying versus what you might be getting. The share price sits near US$292.21 after a 4.6% decline over the past week and 12.1% over the last month, yet the stock has returned 12.1% over 1 year, 74.6% over 3 years and 140.9% over 5 years. Recent coverage has focused on HEICO as a key aerospace and defense name, with investors watching how...

Nuvation Bio (NYSE:NUVB) presented nearly one additional year of follow up data from the TRUST-I and TRUST-II studies of IBTROZI (taletrectinib) at the AACR Annual Meeting 2026. The new data focus on long term efficacy and safety in ROS1 positive non small cell lung cancer, including both treatment naïve and previously treated patients. This update builds on IBTROZI's existing FDA approval and adds fresh clinical detail that has not been reflected in recent coverage of the company. Nuvation...

Cold Case Ice Cream is expanding into more than 1,000 Kroger banner stores across the US. The rollout brings a trend-focused premium ice cream brand to a wide range of Kroger owned banners. The move underscores Kroger's focus on differentiated product assortments in the grocery aisle. For investors watching NYSE:KR, this large scale rollout highlights how Kroger is using branded partnerships to keep its frozen aisle fresh and relevant. The company operates a broad network of supermarket...

For investors wondering whether Micron Technology at US$461.69 is priced for perfection or still offers value, this article walks through what the numbers indicate about the stock. The share price performance has been strong, with returns of 14.5% over 7 days, 12.2% over 30 days, 46.4% year to date, 355.4% over 1 year, around 7x over 3 years, and 454.1% over 5 years. These moves can change how investors think about both upside and risk. These moves are playing out against a backdrop where...

Gold.com (GOLD) drew investor attention after appointing Juan Sartori to its Board of Directors and announcing the retirement of longtime director Beverley Lepine, a governance shift linked to experience in commodities and alternative assets. See our latest analysis for Gold.com. The Board change comes as Gold.com trades at a share price of $47.89, with a 46.45% 90 day share price return and a 71.11% 1 year total shareholder return. This suggests recent momentum has been strong despite a...

GeneDx Holdings (WGS) is back in focus after Ark Invest’s ETFs bought shares for seven straight trading days, alongside a new Niemann Pick disease type C genetic testing collaboration with Zevra Therapeutics. See our latest analysis for GeneDx Holdings. Despite Ark’s buying streak and the new Zevra partnership, GeneDx’s share price has been under pressure, with a 30 day share price return of a 16.25% decline and a year to date share price return of a 42.93% decline, while the three year total...

Recent performance snapshot EyePoint (EYPT) has drawn attention after mixed recent returns, with the share price up about 7% over the past month but showing a decline over the past 3 months and year to date. At a last close of US$13.90 and a market value of about US$1.12b, investors are weighing this performance against the company’s focus on retinal disease treatments and its developing product pipeline. See our latest analysis for EyePoint. That mix of a 7.42% 30 day share price return...

Madison Square Garden Entertainment (MSGE) has drawn fresh investor attention after appointing Allen Lo as Executive Vice President and Chief Legal Officer, a move that more closely connects the live entertainment group to deep technology and media legal expertise. See our latest analysis for Madison Square Garden Entertainment. The appointment of Allen Lo comes at a time when MSGE’s share price has pulled back in the short term. The 1 month share price return shows an 8% decline, but the 90...

In March 2026, Corvus Pharmaceuticals filed a universal shelf registration and expanded its at-the-market equity program with Jefferies to US$200 million, adding flexibility to issue common and preferred stock, debt, warrants and units to support ongoing operations. This expanded financing capacity sits alongside a sharp reduction in full-year 2025 net loss to US$15.28 million and continued clinical progress for lead candidate soquelitinib, together reshaping how investors may view the...

Recent performance snapshot Without a single clear news headline driving the move, Excelerate Energy (EE) has still drawn attention after a mixed run, with a roughly 17% decline over the past month alongside a gain of about 32% in the past 3 months. See our latest analysis for Excelerate Energy. At a share price of $34.65, Excelerate Energy’s recent 17% one-month share price decline contrasts with its 31.8% three-month share price return and 75% three-year total shareholder return, suggesting...

Wondering if Trip.com Group is starting to look like value or a value trap at around US$52 a share? This article breaks down what the current price might be implying. The stock is around US$52.41, with a 1 week return of a 1.4% decline, a 30 day return of a 3.7% decline, and a year to date return of a 29.6% decline, alongside a 1 year return of a 20.7% decline and gains of 38.2% and 32.5% over 3 and 5 years respectively. Recent coverage of Trip.com Group has focused on how the share price...

Parsons (PSN) has attracted attention after recent share price swings, with the stock up about 3% over the past day but showing declines over the past week, month and past 3 months. See our latest analysis for Parsons. That 3% one day share price gain comes after a weaker patch, with the 30 day share price return of 14.52% and year to date share price return of 12.91% both in negative territory, even as the 3 year total shareholder return of 29.74% shows a stronger longer term picture. If...

Tencent Music Entertainment Group (NYSE:TME) just put fresh numbers on the board for FY 2025, with third quarter revenue of C¥8.5b and basic EPS of C¥1.40, set against the backdrop of trailing twelve month revenue of C¥31.7b and EPS of C¥7.05. Over recent quarters, revenue has moved from C¥7.0b in Q3 2024 to C¥7.5b in Q4 2024, C¥7.4b in Q1 2025, C¥8.4b in Q2 2025 and now C¥8.5b in Q3 2025. Quarterly EPS tracked from C¥1.02 to C¥1.27, C¥2.81, C¥1.57 and C¥1.40 over the same stretch. For...

D.R. Horton recently reported quarterly earnings that exceeded analyst expectations even as revenue fell, reflecting affordability pressures and high interest rates weighing on home sales, while also announcing plans for US$2.50 billion in share repurchases and US$500 million in dividends for fiscal 2026. At the same time, the company’s shrinking backlog, lower earnings per share, and weaker return on invested capital highlight mounting pressure on its ability to find profitable growth...

If you are wondering whether Healthpeak Properties is attractively priced or not, its current share price of US$17.65 only tells part of the story. The stock has returned 1.4% over the last week, 5.7% over the last month, and 9.0% year to date, while the 1 year return sits at a 7.6% decline and the 5 year return at a 27.1% decline. These mixed returns sit against a backdrop where Healthpeak Properties is part of the Health Care REITs space, a segment many investors watch for income and...

Granite Construction (GVA) is back in focus after Candelo Capital Management initiated a new position of 49,088 shares, following a record operational year and a large pipeline of committed and awarded projects. See our latest analysis for Granite Construction. Granite Construction's share price has eased in the short term, with a 1 day share price return of a 1.15% decline and a 30 day share price return of a 7.09% decline. However, the 1 year total shareholder return of 67.32% and 3 year...

On 5 March 2026, Waystar announced an expanded collaboration with Google Cloud to integrate Gemini models and data infrastructure more deeply into its AI-powered revenue cycle platform, aiming to scale automation across complex healthcare payment workflows. The next phase of this partnership focuses on agentic AI that combines financial and clinical intelligence from billions of transactions to reshape patient encounters and the full claims lifecycle. Next, we’ll examine how this deeper...

If you are wondering whether Procore Technologies at around US$59 a share is a bargain or just fairly priced, the valuation story is where things get interesting. The stock has recently shown mixed signals, with a 2.8% gain over the last 7 days and 12.7% over the last 30 days, while year to date it is down 15.8% and the 1 year return sits at a 14.0% decline. Recent attention on Procore has centered on its role in construction software and how investors are interpreting the stock's pullback...

Blackstone Mortgage Trust, Inc. has declared a US$0.47 per‑share first‑quarter 2026 dividend on its Class A common stock, payable April 15, 2026 to shareholders of record on March 31, 2026. Separately, investment manager Bamco Inc. NY increased its stake to about 1.01% in the third quarter of 2026, underscoring growing institutional engagement with Blackstone Mortgage Trust’s commercial real estate lending platform. Next, we’ll examine how Bamco Inc. NY’s larger position could shape...

If you are wondering whether Sarepta Therapeutics at US$16.84 is starting to look mispriced, you are not alone, the stock’s valuation picture is more nuanced than the headline share price suggests. The share price has fallen 4.6% over the last week, 5.3% over the last month, 21.0% year to date, and 77.1% over the last year, which has sharply changed how many investors may view the balance between risk and potential reward. These moves sit against a backdrop of ongoing attention on Sarepta’s...

Freshpet has permanently revised its dog food advertising to remove or clarify "human grade" claims following a review by the National Advertising Division. The changes come after a recent regulatory challenge that focused on how clearly the company described the quality standards of its pet food. The updated claims reflect Freshpet's decision to align its marketing more closely with industry advertising guidelines. For investors watching NasdaqGM:FRPT, the move comes at a time when the...

Exact Sciences stock snapshot Exact Sciences (EXAS) has drawn investor attention after recent share price moves, with the stock near US$103.94 and return figures over the past year and past 3 years standing out against its 5 year record. See our latest analysis for Exact Sciences. The recent move in Exact Sciences' share price to around US$103.94 comes after a strong 1 year total shareholder return of 131.39%. However, the 5 year total shareholder return shows a decline of 21.26%, indicating...